Multiple dose pharmacokinetics of ciprofloxacin in preterm babies

Indian Pediatrics

Volumn 41, Issue 10, 2004, Pages 1001-1007

  Aggarwal, Poonam ^a   Dutta, Sourabh ^a   Garg, S K ^a   Narang, Anil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ciprofloxacin; Pharmacokinetics; Preterm

Indexed keywords

CIPROFLOXACIN;

ANAPHYLAXIS; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ENTEROBACTERIACEAE; FEMALE; GESTATIONAL AGE; HUMAN; INDIA; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTIPLE DRUG DOSE; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NONHUMAN; PREMATURITY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SEIZURE; SEPSIS; SIDE EFFECT; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BIRTH WEIGHT; CIPROFLOXACIN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; SEPSIS; STAPHYLOCOCCAL INFECTIONS;

EID: 7044224705     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bang AT, Bang RA, Baitule SB, Reddy MH, Deshmukh MD. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India. Lancet 1999; 354:1955-1961.
2. National Neonatology Forum of India. National Neonatal-Perinatal Database, Report for the year 2000, New Delhi. Publ Noble Vision, p. 47.
3. National Neonatology Forum of India. National Neo-natal-Perinatal Database, Report for the year 2000, New Delhi; Publ Noble Vision, p. 18-19.
4. Schaad UB. Use of the new quinolones in pediatrics. Isr J Med Sci 1994; 30: 463-468.
5. Chysky V, Kapila K, Hullmann R, Arcieri G, Schacht P, Echols R. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 1991; 19: 289-296.
6. Gurpinar AN, Balkan E, Kilic N, Kiristioglu I, Dogruyol H. The effects of a fluoroquinolone on the growth and development of infants. J Int Med Res 1997; 25: 302-306.
7. van den Oever HL, Versteegh FG, Thewessen EA, van den Anker IN, Mouton JW, Neijens HJ. Ciprofloxacin in preterm neonates: Case report and review of the literature. Eur J Pediatr 1998; 157: 843-845.
8. Sarkar S, Singh M, Narang A. Successful treatment of hospital acquired Klebsiella pneumoniae meningitis in a neonate with ciprofloxacin. Indian Pediatr 1993; 30: 913-914.
9. Bannon MJ, Strutchfield PR, Weindling AM, Danjanovic V. Ciprofloxacin in neonatal Enterobacter cloacae septicemia. Arch Dis Child 1989; 64: 1388-1391.
10. Chapman ST. Speller DCE, Reeves DS. Resistance to ciprofloxacin. Lancet 1985; 2: 39.
11. Goepp JG, Lee CKK, Anderson T, Dick JD, Stokoe JM, Eiden J. Use of ciprofloxacin in an infant with ventriculitis. J Pediatr 1992; 121: 303-305.
12. Wessalowski R, Thomas L, Kivit J, Voit T. Multiple brain abscesses caused by Salmonella enteritidis in a neonate: successful treatment with ciprofloxacin. Pediatr Infect Dis J 1993; 12Z: 683-688.
13. Weber A, Chaffin D, Smith A, Opheim KE. Quantitation of ciprofloxacin in body fluids by high pressure liquid chromatography. Antimicrob Agents Chemother 1985; 27: 531-534.
14. Huczko E, Conetta B, Bonner D, Valera L, Stickle T, Macko A, et al. Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998. Int J Antimicrob Agents 2000; 16: 401-405.
15. Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985; 27: 375-379.
16. Reddy MDR, Karan B, Reddy SV, Anjanayelu CH. Glomerular filtration rate in term and preterm infants in the first three weeks of life. Indian Pediatr 1984; 21: 267-269.